In March 2025, the company announced new strategies for a direct-to-purchaser providing of its Wegovy weight loss drug. The company recognized a brand new pharmacy, identified as NovoCare, which might charge buyers $499 every month for entry to the drug, below fifty percent the price of the drug by other pharmaceutical distribution networks.[53]Bei